KKR to Acquire Integer Holdings for $5.7 Billion in All-Cash Deal — Integer Holdings Corporation

Event summary

Integer Holdings reports Q2 2026 sales down 2.6% to $464M, with organic sales decreasing 1.5%.
GAAP operating income from continuing operations fell 42% to $35M.
KKR to acquire Integer in an all-cash transaction valued at $5.7B enterprise value.
Integer stockholders to receive $127 per share in cash under the deal terms.
Company withdraws financial outlook and cancels earnings call due to pending acquisition.

The big picture

KKR's acquisition of Integer Holdings for $5.7 billion underscores the private equity firm's continued interest in the medical device contract manufacturing space. The deal comes amid a backdrop of declining sales and operating income for Integer, highlighting potential opportunities for KKR to streamline operations and drive growth. This transaction reflects broader trends of consolidation within the healthcare sector, as private equity firms seek to capitalize on stable cash flows and long-term growth prospects in medical technology.

What we're watching

Integration Challenges: How KKR will integrate Integer's operations and manage potential disruptions to ongoing business relationships.
Regulatory Approvals: The pace at which regulatory approvals for the acquisition are secured, given the size of the deal.
Strategic Realignment: Whether KKR will realign Integer's product lines or operational focus post-acquisition to enhance value.